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ABSTRACT Computational methods that predict three-dimensional structures from amino acid sequences have become
increasingly accurate and have provided insights into structure-function relationships for proteins in the absence of structural
data. However, the accuracy of computational structural models requires experimental approaches for validation. Here we
report direct testing of the predictions of a previously reported structural model of the C-terminus of the human heart Na1
channel. We focused on understanding the structural basis for the unique effects of an inherited C-terminal mutation (Y1795C),
associated with long QT syndrome variant 3 (LQT-3), that has pronounced effects on Na1 channel inactivation. Here we provide
evidence that this mutation, in which a cysteine replaces a tyrosine at position 1795 (Y1795C), enables the formation of disulﬁde
bonds with a partner cysteine in the channel. Using the predictions of the model, we identify the cysteine and show that three-
dimensional information contained in the sequence for the channel protein is necessary to understand the structural basis for
some of the effects of the mutation. The experimental evidence supports the accuracy of the predicted structural model of the
human heart Na1 channel C-terminal domain and provides insight into a structural basis for some of the mutation-induced
altered channel function underlying the disease phenotype.
INTRODUCTION
Disease-linked inherited mutations of ion channel proteins
are so prevalent that the disorders caused by them, including
epilepsy, febrile seizures, Dent’s disease, and cardiac arrhyth-
mias, are now referred to as channelopathies (Marban, 2002;
Jentsch, 2000; Jentsch et al., 2000; Schwake et al., 2001;
Lossin et al., 2002; Jurkat-Rott and Lehmann-Horn, 2001;
Kullmann, 2002). Expression of ion channels in heterologous
systems allows for investigation of inherited ion channel
defects at the single protein and cellular level to directly
identify the disease-associated alteration in ion channel
function (Clancy and Kass, 2002). However, despite a wealth
of experimental evidence documenting the functional con-
sequences of the disease-linked mutations in ion channels,
understanding the physical mechanisms affected by themuta-
tions at the structural level has been lacking. This is due in
large part to the difﬁculty in obtaining structural information
with high-resolution experimental techniques such as x-ray
crystallography and multidimensional NMR methods in
integral membrane proteins. To date, structural information
is available for only a limited number of ion channel proteins,
despite the fact that ion channels regulate key physiological
cellular and subcellular functions in health and disease
(Miller, 2000a,b).
Computational methods that predict three-dimensional
structures from amino acid sequences have become increas-
ingly accurate and have provided insights into structure-
function relationships for proteins without structural
information (Yang and Honig, 2000; Yang, 2002; Yang
and Wang, 2002). Although the information required to
generate a protein structure is expected to be embedded in its
amino acid sequence, current computational methodologies
that unravel how three-dimensional information is mapped
onto a linear sequence predict low-resolution structures at
best when close homologous structural templates from
protein structural databases are absent. The accuracy of
computational structural models requires experimental
approaches for validation.
Here we report direct testing of the predictions of
a structural model reported by us of the C-terminal domain
of the human heart Na1 channel (Cormier et al., 2002). We
focused on understanding the structural basis for the unique
effects of an inherited C-terminal mutation (Y1795C (YC))
that is associated with variant 3 of the long QT syndrome
(LQT-3) and has pronounced effects on the entry of Na1
channels into a nonconducting inactivated state (Rivolta
et al., 2002; Clancy et al., 2002). The model structure of the
C-terminal domain was based on a remote relationship of the
C-terminal domain and calmodulin structure: the C-terminal
domain was predicted to have a calmodulin-like fold with
one pair of EF-hands packed against each other as in
calmodulin. In this article, we provide evidence that the
naturally occurring mutation, in which a cysteine replaces
a tyrosine at position 1795 (Y1795C), enables the formation
of disulﬁde bonds with a partner cysteine in the channel.
Using the predictions of the model, we identify the cysteine
and show that three-dimensional information contained in the
sequence for the channel protein is necessary to understand
the structural basis of the effects of the mutation. The
experimental evidence supports the accuracy of the predicted
structural model of the C-terminal domain in the human heart
Na1 channel and provides insight into a structural basis for
the mutation-induced altered channel function underlying the
disease phenotype.
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METHODS
Molecular biology
The C-terminal mutations of SCN5A were engineered into wild-type (WT)
cDNA cloned in pcDNA3.1 (Invitrogen, Carlsbad, CA) by overlap
extension using mutation-speciﬁc primers and Quick Change Site-Directed
Mutagenesis Kit (Stratagene, LaJolla, CA). The presence of the mutation
was conﬁrmed by sequence analysis (Rivolta et al., 2001). All constructs
were transiently expressed in HEK293 cells. Transient transfection was
carried out using lipofectamine (Invitrogen) according to the protocol
suggested by the manufacturer. Cells were transfected with equal amounts of
the a-subunit and hb1-subunit (SCNB1), subcloned individually into the
pcDNA3.1 (Invitrogen) vector. In addition, the same amount of CD8 cDNA
was cotransfected as a reporter gene (EBo-pCD vector, American Type
Culture Collection, total cDNA 2.5 mg). CD8 positive cells were patch
clamped 48 h after transfection. Expression of CD8 did not alter the channel
properties, compared with those of stably expressed channel (data not
shown). Control experiments in which CD8 and hb1 were transfected
together using a bicistronic vector (pIRES, Clontech, Palo Alto, CA) were
used to conﬁrm coexpression of hb1 and a-subunits as described above.
Expressed channel biophysical properties were independent of the above
conditions (data not shown).
Electrophysiology
Membrane currents were measured using whole cell and single channel
patch-clamp procedures with Axopatch 200B ampliﬁers and Pclamp 8
(Axon Instruments, Foster City, CA). All measurements were obtained at
room temperature (228C). Single channel recordings employed the following
bath solution (mM): 140 KCl, 5 HEPES, 1 MgCl2, and pH adjusted to 7.4.
Whole cell procedures have been published previously (Abriel et al., 2001).
For single channel experiments, pipettes were coated with Sylgard (Dow
Chemical, Midland, MI) to decrease noise and capacitance of the glass.
Electrode resistance was typically 5–7 MVwhen ﬁlled with internal solution
(110 mM NaCl, 10 mM HEPES, pH adjusted to 7.4). In single channel
experiments, after establishing the cell-attached conﬁguration (seal re-
sistance[ 10 GV), the membrane was held at a holding potential of 120
mV. Test pulses (30 mV, 100 ms) were applied every 0.5 s. Single channel
currents were ﬁltered by a low pass ﬁlter in the clamp ampliﬁer with a cutoff
frequency of 5 kHz and digitized for storage on computer at a sampling
frequency of 20 kHz.
DTT (Dithiothreitol; Sigma, St. Louis, MO) was dissolved in DMSO at
a stock concentration of 1 M. Stock solutions were kept no longer than
1 week. DTT stock solution was diluted into extracellular (bath) solutions to
a ﬁnal concentration of 10 mM immediately before experimental use.
Because DTT is membrane permeable and can be used to modify candidate
intracellular sites by external application (Nassir et al., 2003), cells were ﬁrst
incubated in DTT-containing solutions for at least 30 min at room
temperature before patch-clamp experiments. DTT (10 mM) was maintained
in external solutions during each experiment, and KCl (3 M) was used as
a reference electrode to compensate for junction potentials caused by 10 mM
DTT. Alternatively, in speciﬁed experiments, DTT (50 mM) was added to
the external solution and then applied by perfusion to patched cells. Effects
on membrane currents reached steady state and were recorded in the
presence of DTT after 10-min exposure periods. These effects were
reversible upon the return to DTT-free external solutions (within 10 min).
The effects recorded on the decay of Na1 channel currents were the same for
each method of DTT application.
Data analysis
Capacitative and leak currents were eliminated by digital subtraction of
averaged null sweeps. Idealization of single channel currents and the
measurement of open time were carried out with the program SKM (QUB
suit, U. Buffalo; Premkumar et al., 1997; Qin et al., 1996). Further analysis
was carried out using Excel (Microsoft, Seattle, WA) and Origin (Microcal
Software, Northampton, MA). Data are represented as mean6 SE. Dannet’s
t-test was used to compare statistical signiﬁcance among four groups;
p\ 0.05 was considered statistically signiﬁcant.
Model
Details of the model used to predict the C-terminal domain of the Na1
channel have been published previously by us (Cormier et al., 2002).
RESULTS
The inherited mutation Y1795C slows the
onset of inactivation
Open state Na1 channel inactivation, due to rapid block of
the inner mouth of the channel pore by the (a-subunit)
cytoplasmic linker between domains III and IV of the
channel that occurs within milliseconds of membrane
depolarization (Stuhmer et al., 1989; West et al., 1992;
Vassilev et al., 1988, 1989), is evident as brief channel
openings followed by quiescent periods in single channel
recordings and in the decay of peak inward whole cell or
macroscopic averaged currents. We previously reported that
the inherited mutations Y1795C (associated with long QT
variant 3) and Y1795H (associated with Brugada Syndrome)
had opposite effects on both single channel gating kinetics
and the time course of open state inactivation measured in
whole cell recordings (Liu et al., 2002). Here we varied
systematically the amino acid substitution for Tyr1795 to
determine whether a physical chemical property such as
charge or molecular size could be causally linked to the
altered rate of open state inactivation. Fig. 1 illustrates the
experiments by showing the effects of replacement of
Tyr1795 by Ser (Y1795S (YS)). This mutation does not
signiﬁcantly alter channel mean open time (MOT) or open
state inactivation kinetics (right traces and histogram, Fig.
1), in contrast to the effects of the Y1795C mutation and the
previously reported effects of the Y1795H mutation. What
properties of the Cys in this position underlie the apparently
distinct slowing of inactivation and prolongation of channel
mean open time?
To explore this, we focused on the kinetics of open state
inactivation measured under whole cell recording conditions
and over a broad range of voltages. Na1 channel open state
inactivation kinetics are voltage-dependent: inactivation of
wild-type channels becomes faster with increasing de-
polarization. This voltage dependence of WT channels,
which is most prominent at voltages negative to 10 mV, is
evident in the data summarized in Fig. 2 A, which plots the
time for peak inward current to decay by a factor of two as
a function of test voltage. The Y1795C (¤) mutation slows
open state inactivation over the range of voltages tested.
Importantly, the slowing (increase in mean open time) is
most apparent at voltages positive to10 mV, where there is
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little change in the time course of inactivation with further
depolarization, i.e., where there is a weak voltage de-
pendence to inactivation kinetics. The effect of this mutation
on the kinetics of the onset of inactivation appears to be
linked to the presence of the cysteine thiol group, because
replacement of Tyr1795 by either alanine or serine, amino
acids with similar structures but lacking sulfur atoms, fails to
slow inactivation kinetics (Fig. 2, A and B), and none of the
mutations affected the voltage dependence of activation
(Table 1). We found similar results when we replaced
Tyr1795 by Arg, Glu, and His (see Table 1) and, importantly,
found no effect on gating kinetics when the tyrosine was
replaced by phenylalanine. As summarized in Table 1, the
time to half decay of peak whole cell current varies with
the following order for residues substituted at codon 1795:
C  A [ Y (WT) ¼ F [ S [ H [ E ¼ R. Alteration
in inactivation gating does not vary systematically with
either charge or size of substituted residues at position 1795,
suggesting that mutation of Tyr1795 disrupts a structural
motif of the C-terminal tail, which, in turn, plays a key role
in controlling channel gating. Furthermore, because of the
unique effects of the cysteine substitution, our results raise
the possibility that the slowing of inactivation by the
Y1795C mutation may be uniquely related to the presence
of a Cys residue at this location. This suggests that disulﬁde
bonds may form in the channel C-terminus when Tyr1795 is
replaced by Cys in the disease-associated Y1795C mutation.
Further, the data suggest that putative disulﬁde bond
formation may impede transitions from the open to
inactivated states (slow the onset of inactivation and
prolongs channel mean open time).
Disulﬁde bond formation underlies the effects
of the Y1795C mutation on inactivation
To test this possibility, we used a pharmacological approach
and studied the effects of DTT, a reducing reagent of
disulﬁdes in proteins, on channel inactivation for channel
FIGURE 1 Inherited mutation Y1795C alters single channel properties of wild-type cardiac sodium channels. Cell-attached patch recordings are shown for
wild-type (left), Y1795C (middle), and Y1795S (right) channels. Recordings were obtained in response to test pulses (10 mV, 100 ms) applied at 2 Hz from
120 mV. Current recordings of individual and consecutive sweeps are shown to emphasize the effects of inherited mutations on channel opening kinetics.
Ensemble currents (constructed by averaging 500 consecutive sweeps) are shown for each construct below the individual sweeps. Open time histograms were
generated for each construct using 200-ms bins of all events recorded from 500 to 1000 sweeps. Patches used included three or fewer channels. MOT was
estimated by the best-ﬁt double exponential functions to each histogram. The ﬁtted curves are illustrated as dashed lines in each panel. The resulting MOT
estimates based on the extracted time constants are 0.766 0.05 ms (WT, n¼ 4); 1.096 0.8 ms (YC, n¼ 5); and 0.726 0.04 ms (YS, n¼ 3); p¼ 0.01 for YC
versus WT, YS versus WT (NS).
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constructs in which we systematically varied residue 1795.
We focused on the time course of the onset of inactivation
and ﬁrst compared the effects of DTT exposure on the onset
kinetics of WT and Y1795C channels. As illustrated by the
current traces in Fig. 3 A, DTT reversibly speeds the onset of
inactivation of Y1795C channels, but has no effect on WT
channels for which there is a Tyr at residue 1795. Fig. 3 B,
which illustrates the effects of DTT on inactivation kinetics
over a broad range of voltages, conﬁrms this and, in addition,
shows that DTT does not affect the kinetics of the onset of
inactivation for channels in which the Tyr1795 is replaced by
Ala (Y1795A (YA)). This result serves as a baseline against
which the properties of mutant channels can be compared
because it implies that, in the WT or Y1795A channel, it is
not likely that disulﬁde bonds (and their disruption by DTT)
contribute to these to biophysical properties of the channel.
However, when Y1795C channels are treated with DTT,
there is a signiﬁcant speeding of the onset of inactivation,
such that inactivation kinetics of DTT-treated Y1795C
channels closely resemble the kinetics of WT channels
(panel A, plot and inset). This is quantiﬁed in Fig. 3 C, which
summarizes the effects of DTT treatment on inactivation
kinetics measured at 110 mV. There is no signiﬁcant effect
of DTT on WT or YA channels (compare solid and open
bars), but there is a signiﬁcant decrease in t1/2 for YC
channels, and t1/2 for YC channels 1 DTT is not signiﬁ-
cantly different from t1/2 of WT channels. These data provide
evidence that disulﬁde bond formation may participate in
some of the functional changes in channel gating induced by
the LQT-3 mutation Y1795C. Interestingly, although not
a focus of this study, we found no effect of DTT treatment
on sustained current (Isus, bursting activity) of Y1795C chan-
nels (normalized Isus  DTT, 0.366 0.04 (n ¼ 14);1 DTT,
0.3 6 0.02, n ¼ 3; p ¼ not signiﬁcant (NS)), and thus not
all disease-associated function caused by the Y1795C mu-
tation is likely to be mediated by disulﬁde bond formation.
Prediction of cysteine partners in disulﬁde bond
by a mathematical model
Because the tertiary structure of the Na1 channel C-terminal
domain has not yet been solved, we relied upon a model
structure, previously reported by us, based on a remote
relationship between the C-terminal domain and the structure
of calmodulin. The model predicts that residue 1795 is
almost adjacent to a cysteine molecule, residue C1850 (Fig.
4 A). Interestingly the residues are predicted to be in two
different a-helices (H1 and H4; see Fig. 4, B and C), which
cross in a region where two pairs of EF-hands are predicted
to be packed against each other. The model also predicts that
residue F1794, adjacent to Y1795 in the linear sequence, is
far removed from C1850 (see Fig. 4 A), and thus the
mutation F1794C would not be likely to form a disulﬁde
bond with residue C1850 according to predictions of the
model.
Experimental validation of model-predicted
tertiary structure
We thus tested both of these model-deﬁned predictions and
summarize the results of our experiments in Fig. 5. First, we
FIGURE 2 Distinct properties of
Y1795C channels: effects on the kinet-
ics of the onset of inactivation. Residue
Y1795 (WT, Y, ) was mutated to Cys
(Y1795C, C, ¤), Ala (Y1795A, A, ),
Phen (Y1795F, F, d), and Ser
(Y1795S, S, n). (A) The plot shows
the time for peak inward current elicited
by the test voltages to decay to 50% of
peak (t1/2) plotted versus test pulse
voltage for each construct. Data shown
are mean6 SE: n ¼ 8 (WT); n ¼ 7 (C);
n ¼ 6 (S); n ¼ 8 (A). (B) Summary plot
of time to half decay (t1/2) measured
at 110 mV versus channel construct.
Experimental numbers are as in A.
*p \ 0.01 versus WT; **NS versus
WT.
TABLE 1 Whole cell properties of Y1795 mutations
Residue at 1795 Activation (V1/2) (mV) t1/2 (110 mV) (ms)
Y (WT) 23.0 6 1.5 0.53 6 0.03
C 24.6 6 1.8NS 0.90 6 0.05*,#
A 19.2 6 1.5NS 0.58 6 0.02NS,#
S 19.8 6 1.1NS 0.47 6 0.01NS,#
H 20.1 6 2.1NS 0.42 6 0.03**,#
E 21.3 6 1.8NS 0.32 6 0.03*,#
R 20.9 6 0.5NS 0.29 6 0.04*,#
F 22.9 6 0.25NS 0.52 6 0.01NS,#
The residue at position 1795 (i.e., C ¼ C1795) deﬁnes the notation used in
the table. Onset of inactivation kinetics is summarized as t1/2 (time of half to
peak in milliseconds) measured at110 mV. Each value is mean 6 SE from
six to eight experiments. *p\0.01 versus WT; **p\0.05 versus WT; NS,
not signiﬁcant versus WT; #p\ 0.01 versus C1795.
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replaced the Cys at position 1850 in the Y1795C construct
with an Ala (C1805A_Y1795C) and then tested the effects of
the reducing agent DTT on the kinetics of open state
inactivation. If the disulﬁde bonds form between Cys1795 and
Cys1850, then this substitution should prevent bond forma-
tion and ablate the effects of DTT on these gating
parameters. Fig. 5 A shows that this is the case. Fig. 5 B
shows that replacement of the Phe at position 1794 by Cys in
the WT channel (with a Tyr at position 1795; construct
F1794C 1 Y1795) does not induce sensitivity of in-
activation kinetics to DTT. These results are consistent with
a C-terminal structure in which residue 1795 is sufﬁciently
close to residue 1850 to enable disulﬁde bond formation
when both residues are Cys molecules and also with
a structure for which residues 1850 and 1794 are separated
physically by distances that preclude disulﬁde bond
formation. The predictions of our model are consistent with
these experimental results.
DISCUSSION
Mutation Y1795C and pathophysiology:
altered inactivation
Open state inactivation of voltage-gated Na1 channels is due
to rapid block of the inner mouth of the channel pore by the
cytoplasmic linker between domains III and IV that follows
voltage-induced channel openings (Stuhmer et al., 1989;
West et al., 1992; Vassilev et al., 1988, 1989; Catterall,
1995). Disruption of inactivation by inherited mutation of
the III/IV linker (Bennett et al., 1995) or its docking sites,
underlie channelopathies in skeletal muscle, neuronal tissue,
and in the heart (Green et al., 1998; Lossin et al., 2002;
Keating and Sanguinetti, 2001; Balser, 2002; Lerche et al.,
2001; Moxley III, 2000; Steinlein and Noebels, 2000). The
Y1795C mutation also disrupts inactivation, but not by direct
alteration of the inactivation gate or its previously identiﬁed
docking sites. This mutation, and several others associated
FIGURE 3 Evidence for disulﬁde
bond modiﬁcation of inactivation in
Y1795C mutant channels. Cells ex-
pressing WT channel (, d), A1795 (,
n), or C1795 (}, ¤) mutant channels
were treated (solid symbols) or not
treated (open symbols) with DTT. (A)
The upper row shows current traces
recorded from cells before, during, and
after washout of exposure to DTT (50
mM) in the external bath. Currents are
shown for WT (left) and YC channels
(right) recorded at 110 mV. (B). The
mean (6 SE) time to half current decay
(t1/2) is plotted versus test pulse voltage
for each construct. The number of
experiments was from six to nine for
each construct. (C) The bars summarize
t1/2 measured at110 mV in the absence
(open) and presence (solid) of DTT (10
mM). *p \ 0.01 compared with un-
treated and with WT and YA; **NS
versus WT.
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FIGURE 4 Structural model of the C-terminal domain in
the SCN5A Na1 channel. (A) The linear sequence of the
proximal region of the C-terminal tail of SCN5A. The
arrows indicate positions of F7194 (green), Y1795 (red),
and C1850 (blue). (B) Model-predicted C-terminal struc-
ture. The N-terminal half (residues 1773–1863) of the
SCN5A C-terminal domain was predicted to contain two
EF-hand structural motifs that are packed to adopt a folding
topology similar to the EF-hands in calmodulin (Cormier
et al., 2002). The helix barrels H1-H2 show the ﬁrst EF-
hand structural motif in the model; the H3-H4 helix barrels
show the second EF-hand structural motif. The three-
dimensional ball-and-stick models show the predicted
positions of the residues Y1795C and C1850 in the
structural model. The sulfur atoms in the cysteines are
colored in yellow. These two atoms are separated by 4 A˚ in
the model structure. Residue F1794 that appears from the
back of H1 helix is also shown in ball-and-stick model. (C)
The helix wheel for H1 helix shows schematically the
amphipathic nature of the H1 helix. The residues that are
expected to be involved in the formation of a disulﬁde
bond in the Y1795C mutant are shown in green. The
ionizable residues in H1 helix are colored in red.
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both with LQT-3 and Brugada Syndrome, occur in an acid
rich region of the C-terminal tail of the channel (An et al.,
1998; Bezzina et al., 1999; Veldkamp et al., 2000; Akai et al.,
2000; Wei et al., 1999; Ackerman et al., 2001; Rivolta
et al., 2001; Baroudi and Chahine, 2000; Deschenes et al.,
2000; Wehrens et al., 2000).
Mechanistic basis for altered function: insight
from molecular modeling
How might inherited C-terminal mutations, and in particular
the Y1795C LQT-3 mutation, alter channel inactivation?
Without a solved structure for Nav1.5 (SCN5A), it is difﬁcult
to reconcile the functional changes caused by the Y1795C
mutation with information that is based solely on its cDNA
sequence. However, the experimental results presented in
this work provide insight into the plausible structure of the
C-terminal domain, and thus can be used to understand how
this mutation may alter channel inactivation. In a previous
study, we constructed a molecular model for the ﬁrst half of
the C-terminal domain with a remote homologous structural
template calmodulin. Based on this structural model, the
distance between the Ca atoms of Y1795 and C1850 is
estimated to be 6.8 A˚. In general, a disulﬁde bond involves
two cysteines for which the average Ca distance is 7 A˚.
Y1795C and C1850 are thus expected to be in range to form
a disulﬁde bridge, provided that the molecular model is
reasonably accurate (see Fig. 4). We have demonstrated with
CD spectroscopy that the ﬁrst half of the C-terminal domain
is indeed consistent with the calmodulin structure in that the
C-terminal domain forms a structure comprised of mostly
a-helices (Cormier et al., 2002). In this work, we have further
conﬁrmed that the predicted head-to-tail distance for part of
the model structure with 56 consecutive residues is in range
to form a disulﬁde bond between C1850 and C1795. This
head-to-tail distance is extremely sensitive to the tertiary
structure of the intervening residues; any structural discrep-
ancies in the orientation and packing of the helices between
these two residues would introduce a large range of variation
in this head-to-tail distance. The implication of the observed
disulﬁde bond formation is that the tertiary structure for
the C-terminal domain that consists of a pair of EF-hand
structural motifs must be a reasonable model for the ﬁrst half
of the C-terminal domain.
The structural model has provided insights into the
question as to how a disulﬁde bond in the C-terminal do-
main might introduce such a drastic changes in inactivation
kinetics involving the III-IV loop and the pore domain.
Mutational analysis revealed distinct effects of the Y1795C
mutation that are particularly signiﬁcant at positive voltages.
At voltages positive to 0 mV, the kinetics of the onset of
open state inactivation are signiﬁcantly and uniquely slowed
by the Y1795C mutation independent of test pulse voltage.
Intuitively, this voltage independent effect may involve
intradomain interactions, as the disulﬁde bond formation
observed in this work. Two speculative models may be
considered that involve the C-domain in the inactivation
mechanism: 1), the C-terminal domain competes with the III-
FIGURE 5 Experimental tests of
structural model predictions. The ef-
fects of DTT (10 mM) were measured
on channels in which the possible
cysteine pairs were probed by mutation.
In each panel, the upper row illustrates
currents measured (at 110 mV) in the
absence and presence of DTT (10 mM).
The lower row plots inactivation t1/2
versus test pulse voltage in the absence
(open) and presence (solid) of DTT 10
mM. (A). The Cys at position 1850 was
replaced by Ala, and Tyr1795 was
replaced by Cys to generate construct
C1850A_Y1795C. Plotted is mean 6
SE data (n ¼ 6 for each data set). (B)
The Phe at position 1794 was replaced
by Cys, and the Tyr at position 1795
was not changed to make construct
F1794C_Y1795. Shown are mean 6
SE data (n¼ 4–6 for each construct). At
10 mV, there is no signiﬁcant difference
between DTT-free or DTT-containing
data (p[ 0.3 in both cases).
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IV loop binding site in the opened pore domain, such that the
III-IV loop can not effectively bind to the pore domain to
inactive (block) the channel; or 2), the C-terminal domain
interacts with the III-IV loop to hinder the interaction of the
III-IV loop with the opened pore domain. A C-terminal
domain stabilized by the interhelix disulﬁde bond can en-
hance both mechanisms and in turn slow down the inactiva-
tion kinetics.Moreover, the fact that polar residues in position
1795 speed up the kinetics of the inactivation is consistent
with the possibility that regions near the mutation site may be
close to the interaction interface of the C-terminal domain.
This region is hydrophobic (see Fig. 4 B) and is likely to
interact with the hydrophobic surface exposed in the opened
pore domain or the isoleucine-phenylalanine-methionine
hydrophobic motif in the III-IV loop. The experimental work
so far has not provided direct evidence to support either of the
models above. Since the III-IV loop is highly positively
charged, the second model also suggests that long range
electrostatic interactions involving the negative charge near
the mutation site (see Fig. 4 B) can signiﬁcantly affect the
interactions and in turn the kinetics of the inactivation
mechanism. These possibilities, which need to be tested with
further experimental work, offer a structural basis for life
threatening arrhythmias that accompany inherited mutations
of the C-terminal domain of the human heart Na1 channel.
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